Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
Press release content from Business Wire. The AP news staff was not involved in its creation. Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates May 10, 2021 GMT BEDFORD, Mass.--(BUSINESS WIRE)--May 10, 2021-- Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by up-regulating protein expression with RNA-based medicines, today reported financial results for the first quarter of 2021 and provided business updates. “The momentum we are seeing with STK-001 in the clinic is driven...